Nontuberculous Mycobacterial Infections

Slide 1 · Nontuberculous mycobacterial infections

Etiology · host susceptibility · pathogenesis · morphology · clinicopathologic diagnosis

A pathology lecture organized around host–organism interactions

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Identify the major NTM pathogens and their environmental reservoirs.

Connect pulmonary and disseminated disease to distinct host vulnerabilities.

Explain neutrophil-mediated injury, macrophage-rich morphology, and diagnostic pitfalls.

Interpret species identification in clinical and pathologic context.

Slide 3 · NTM: A group defined by exclusion

Genus Mycobacterium

M. Tuberculosis

Excluded: Tuberculosis

Nontuberculous mycobacteria

Focus of this lecture

M. Leprae

Excluded: Leprosy

Slide 4 · Acid-fastness reflects the mycobacterial cell wall

Mycobacteria contain unusual lipid-rich cell walls.

Mycolic acids contribute to resistance to acid–alcohol decolorization.

An acid-fast stain identifies a property of the genus—not the species.

Mycobacterial bacilli

Schematic · not a stained specimen

Slide 5 · NTM disease has become more prevalent worldwide

An increase in NTM disease prevalence worldwide.

The source provides no current numerical incidence or prevalence series.

Interpret changing frequency separately from the clinical spectrum of disease.

Slide 6 · The NTM group comprises many species

Approximately 150 NTM species in the source

A subset are frequent human pathogens

Species identification informs management

Species diversity does not imply equal pathogenicity.

Slide 7 · Three major pathogens anchor the clinical discussion

Mycobacterium avium complex

MAC

M. Abscessus complex

Rapidly growing NTM complex

M. Kansasii

Distinct species

Slide 8 · MAC is a clinically defined species complex

Mycobacterium avium complex (MAC)

M. Avium

Member

M. Intracellulare

Member

M. Chimaera

Molecularly distinguished member

Slide 9 · Traditional identification may not resolve MAC members

Historical limitation

Implication

Physical / biochemical tests

M. avium and M. intracellulare are difficult to separate

Similar clinical features

Grouping as MAC remains clinically useful

Species-level uncertainty

Avoid claiming identification beyond the assay

Slide 10 · Molecular methods refine MAC identification

Sample containing an NTM

Molecular identification

Resolve M. Avium / M. Intracellulare / M. Chimaera

The source states molecular methods better distinguish these MAC species.

Slide 11 · Species identity matters because therapy differs

Different treatments for leading NTM pathogens.

Report the identified species or complex rather than “AFB positive” alone.

This lecture does not specify drug regimens or guideline algorithms.

Acid-fast rods

Species assignment requires additional methods

Slide 12 · Environmental reservoirs: Soil and water

Water

Ubiquitous environmental source

Soil

Ubiquitous environmental source

Human exposure

Does not automatically equal clinical disease

Slide 13 · Exposure and disease are distinct concepts

Environmental NTM exposure

Usually effective host defense

Disease in a susceptible host

The diagram represents susceptibility—not a deterministic sequence.

Slide 14 · Person-to-person transmission is uncommon

NTM usually arise from environmental reservoirs, not ordinary interpersonal spread.

The source describes little human-to-human transmission.

Do not import the epidemiologic model of contagious pulmonary tuberculosis.

Slide 15 · Cystic fibrosis is a transmission exception

A small number of person-to-person transmission cases in cystic fibrosis.

This exception does not overturn the predominantly environmental transmission pattern.

The source does not specify transmission rates or infection-control protocols.

Slide 16 · Four major clinical NTM syndromes

Chronic pulmonary disease

Most frequent presentation

Lymphadenitis

Lymph-node involvement

Cutaneous disease

Skin / soft tissue

Disseminated disease

Multiorgan infection

Slide 17 · The lung is the predominant disease site

Chronic pulmonary infection is the commonest clinical presentation.

Structural lung disorders are prominent predispositions.

Pulmonary phenotype differs from disseminated MAC in profound T-cell deficiency.

Pulmonary disease predominates

Distribution schematic · not radiologic imaging

Slide 18 · Host defense usually prevents NTM infection

Environmental mycobacteria

Intact innate and cellular defenses

Infection ordinarily prevented

The susceptibility spectrum matters more than exposure alone.

Slide 19 · Structural lung damage creates susceptibility

Bronchiectasis

Damaged and dilated bronchi

Cystic fibrosis

Abnormal airway secretions

Primary ciliary dyskinesia

Impaired ciliary clearance

COPD / pneumoconiosis

Chronic structural lung injury

Slide 20 · Bronchiectasis: Permanent bronchial dilation

In the Robbins lung chapter, infection and inflammation damage bronchial wall smooth muscle and elastic tissue.

Defective airway clearance fosters ongoing infection.

NTM infection is one possible complication in structurally abnormal lungs.

Inflammation → bronchial dilation

Schematic

Slide 21 · Bronchiectasis and NTM can reinforce lung injury

Defective clearance / pre-existing bronchiectasis

Opportunity for NTM pulmonary disease

Chronic inflammatory airway burden

Conceptual amplification model; Causation in any individual patient requires clinical evidence.

Slide 22 · Cystic fibrosis supplies a distinct airway substrate

Abnormal epithelial ion transport

Thick secretions and impaired clearance

Obstruction, infection and bronchiectasis

Robbins also lists NTM among CF-associated opportunistic pulmonary pathogens.

Slide 23 · Primary ciliary dyskinesia compromises clearance

Dysfunctional motile cilia impair mucociliary transport.

Recurrent infections and bronchiectasis follow the clearance defect.

This constitutes a structural susceptibility pathway for NTM.

Impaired motile cilia

Schematic

Slide 24 · COPD and pneumoconiosis are relevant risk contexts

Predisposing condition

Clinicopathologic framing

Chronic obstructive pulmonary disease

Pre-existing altered lung architecture / function

Pneumoconiosis

Chronic occupational lung injury / structural disease

Practical interpretation

Consider the diseased lung when interpreting NTM isolation

Slide 25 · Immune suppression creates another vulnerability axis

HIV infection

T-cell immunodeficiency may be severe

Transplantation

Immunosuppressive state

TNF inhibitor therapy

Altered antimycobacterial host response

Slide 26 · Profound T-cell deficiency changes disease distribution

Marked T-cell immunodeficiency

MAC proliferates extensively

Widespread multiorgan infection

In this setting, macrophage-rich tissue infection may contain very large numbers of bacilli.

Slide 27 · Rare defects implicate IL-12 / IFN-γ immunity

Inherited defects in the IL-12/IFN-γ pathways.

Rare anti-IFN-γ autoantibodies are another predisposing condition.

These features highlight the importance of the cellular immune axis.

IL-12

IFN-γ

Inherited pathway defects or anti–IFN-γ antibodies

Schematic immune axis

Slide 28 · Two broad host routes lead to NTM disease

Predominant host vulnerability

Typical disease context

Damaged airways / impaired clearance

Chronic pulmonary infection

Major T-cell immunodeficiency

Disseminated MAC infection

Procedure / injured tissue

Rapidly growing NTM wound infection

Slide 29 · Neutrophils participate in antimycobacterial defense

Neutrophils as critical host-defense cells.

The same cell population can release inflammatory mediators.

Inflammation may worsen tissue disease while responding to pathogens.

Defense + inflammatory mediators

Neutrophil response

Schematic

Slide 30 · MAC induces neutrophil extracellular traps

MAC encounters neutrophils

Extracellular DNA–protein networks form

Networks bind pathogens

NET = neutrophil extracellular trap; A host-defense response.

Slide 31 · NETs are extracellular DNA–protein frameworks

NETs consist of extracellular strands of DNA and proteins.

Their role in binding pathogens.

They are mechanistically distinct from granulomas and from bacilli.

Extracellular DNA–protein network

Schematic

Slide 32 · IL-8 release amplifies local inflammatory signaling

MAC-associated neutrophil activation

IL-8 release

Increased inflammatory signaling

The source links IL-8 release to the neutrophil response in NTM lung disease.

Slide 33 · Neutrophil metalloproteinases contribute to injury

Neutrophil activation

Matrix metalloproteinase release

Worsening lung inflammation

Host-mediated injury accompanies the antimicrobial response.

Slide 34 · Neutrophil defense and tissue injury coexist

Host-protective activity

Potential pathologic consequence

NET formation binds pathogens

Extracellular inflammatory material in affected tissue

IL-8 release

Amplified inflammatory signaling

Matrix metalloproteinases

Contribution to destructive airway inflammation

Slide 35 · Rapidly growing NTM: Postsurgical or traumatic infection

Surgical procedure / trauma

Local breach of tissue barrier

Rapidly growing NTM infection

An association; No particular procedure or species-specific rate is asserted.

Slide 36 · Medical-device biofilms provide a source of NTM

NTM biofilms on medical devices are a documented infection source.

Surface-associated bacteria create a device-linked infection context.

Microbiologic evaluation requires attention to the implicated device.

Surface-associated NTM biofilm

Schematic—not device imaging

Slide 37 · Biofilm-associated infection is a different pathway

Pulmonary NTM disease

Device-associated NTM infection

Background lung susceptibility

Presence of a colonized material surface

Chronic airway symptoms / radiologic changes

Local or device-linked presentation

Source may be environmental

Biofilm is a documented infection source

Slide 38 · Disseminated MAC: Systemic clinical phenotype

Marked T-cell immunodeficiency predisposes to widespread dissemination.

MAC organisms proliferate in several organs.

Patients commonly develop fever, drenching night sweats and weight loss.

Slide 39 · Disseminated MAC affects multiple organ systems

Lungs

Extensive organism proliferation

Gastrointestinal tract

Extensive organism proliferation

Lymph nodes

Macrophage-system involvement

Liver / spleen

Macrophage-system involvement

Slide 40 · Dissemination targets the mononuclear phagocyte system

Disseminated MAC

Infected tissue macrophages

Lymph nodes, liver and spleen

Multiorgan macrophage infiltration underlies characteristic pathology.

Slide 41 · Macrophage accumulation enlarges affected organs

Involved lymph nodes can enlarge.

Liver and spleen enlargement may accompany dissemination.

The organ changes are linked to extensive macrophage involvement.

Lymph node

Liver

Spleen

Mononuclear phagocyte system

Slide 42 · Affected organs may show yellowish pigmentation

Possible yellowish discoloration of involved organs.

The cause is the large burden of bacteria within swollen macrophages.

Color alone is neither diagnostic nor sufficient for species identification.

Lymph node

Liver

Spleen

Possible yellowish discoloration

Slide 43 · Macrophages may be packed with acid-fast bacilli

Macrophage containing numerous acid-fast organisms

Hallmark described for MAC in patients with HIV.

Abundant acid-fast bacilli lie within macrophages.

Schematic morphology—not a histology image

Slide 44 · Granulomas may be sparse in severe MAC disease

Feature

Robbins description in HIV-associated MAC

Organism burden

Often abundant within macrophages

Granulomas

Rare

Lymphocytes

Rare

Tissue destruction

Rare

Slide 45 · Heavy bacillary burden need not mean destructive lesions

In advanced immunodeficiency, heavy intracellular infection may dominate histology.

Granulomas, lymphocytes and tissue destruction can be minimal.

Interpret bacterial burden together with the host’s immune state.

Slide 46 · T-cell competence helps explain morphology

Severe immune deficiency: disseminated MAC

T-cell-mediated response: TB context

Organism-laden macrophages may predominate

Granulomatous response is characteristic

Granulomas can be rare

Caseating or noncaseating granulomas occur

NTM-specific source observation

Contrast drawn from neighboring tuberculosis section

Slide 47 · Pulmonary MAC presents with a productive cough

Without HIV or another severe immunodeficiency, MAC mainly involves the lung.

The illness may cause a productive cough.

Fever and weight loss occur in some patients.

Slide 48 · Pulmonary imaging may show upper-lobe fibrocavitary disease

Fibrocavitary lesions as one pulmonary pattern.

These are described primarily in the upper lobes.

The schematic conveys distribution, not CT or radiographic evidence.

Predominantly upper-field cavitary changes

Distribution schematic · not radiologic imaging

Slide 49 · An alternative pattern is nodular bronchiectasis

Bronchiectasis can coexist with multiple small pulmonary nodules.

Multifocal clusters of small nodules.

This contrasts with the predominantly upper-lobe fibrocavitary pattern.

Small clustered nodules with dilated airways

Distribution schematic · not radiologic imaging

Slide 50 · Two imaging phenotypes support pulmonary recognition

Fibrocavitary phenotype

Nodular-bronchiectatic phenotype

Fibrocavitary lesions

Bronchiectasis

Predominantly upper-lobe distribution

Multifocal clusters of small nodules

One possible radiographic pattern

Another possible radiographic pattern

Slide 51 · Lymphadenitis is a recognized NTM manifestation

NTM disease is not restricted to the lung.

Lymphadenitis is one of the four clinical presentations listed by Robbins.

The supplied NTM section does not provide node-specific histologic criteria.

Slide 52 · Cutaneous disease is part of the NTM spectrum

NTM can manifest as cutaneous infection.

Rapidly growing NTM may be associated with postsurgical or traumatic infection.

The source does not distinguish specific skin morphologies by species.

Slide 53 · Organ pattern and host context should be read together

Presentation

Context highlighted in Robbins

Chronic pulmonary disease

Structural lung damage and impaired clearance

Disseminated MAC

Marked T-cell immunodeficiency

Skin / procedure-related infection

Postoperative or posttraumatic infection with rapid growers

Device-linked infection

Biofilm on a medical device

Slide 54 · An NTM evaluation has three distinct questions

What is the clinical / tissue syndrome?

Which host vulnerabilities are present?

What species or complex is identified?

Interpretation integrates phenotype, susceptibility and microbiology.

Slide 55 · Acid-fast morphology does not assign a species

The acid-fast cell-wall property is shared across mycobacteria.

An acid-fast stain cannot, by itself, assign MAC vs M. Abscessus vs M. Kansasii.

Molecular differentiation has particular value within MAC.

Mycobacterial bacilli

Schematic · not a stained specimen

Slide 56 · Microbiologic speciation is clinically consequential

NTM detected / suspected

Organism or complex identified

Therapy selection differs among pathogens

Robbins stresses species identification; Regimen details lie outside the supplied source.

Slide 57 · A diagnosis needs more than pathogen vocabulary

Finding

What it supports—and does not establish

Acid-fast organisms

Mycobacterial morphology; not a species

Abnormal chest imaging

Pulmonary phenotype; not organism identity

MAC species identified

Microbiologic identity; clinical context still matters

Macrophage-rich tissue with AFB

Typical in advanced HIV-associated MAC; assess host

Slide 58 · Case: Chronic cough in a damaged airway

Clinical scenario

A person with established bronchiectasis develops persistent productive cough. Imaging shows small clustered nodules and bronchiectatic airways.

Which NTM pattern is most relevant?

A nodular-bronchiectatic pulmonary pattern. Correlate with microbiologic identification; The vignette alone cannot prove NTM disease.

Slide 59 · Case: Advanced HIV and systemic symptoms

Clinical scenario

A patient with profound T-cell immunodeficiency develops fever, drenching night sweats, weight loss and hepatosplenomegaly.

What organism–morphology pairing fits?

Disseminated MAC; Tissues may contain swollen macrophages packed with acid-fast bacilli, often with few granulomas.

Slide 60 · Case: Infection following an invasive procedure

Clinical scenario

A patient develops a persistent local soft-tissue infection after a surgical procedure. Organism workup suggests a nontuberculous mycobacterium.

Which NTM group deserves consideration?

Rapidly growing NTM, given the source association with postsurgical and posttraumatic infection. Definitive identification is required.

Slide 61 · Case: Infection around a medical device

Clinical scenario

An NTM-associated infection is investigated in a patient with an implanted device; The device surface is suspected as a reservoir.

Which biological process explains the source?

Biofilm development on medical devices is a well-documented source of NTM infection.

Slide 62 · Avoid four common interpretive errors

Do not equate all acid-fast organisms with M. Tuberculosis.

Do not treat MAC members as universally distinguishable by older biochemical methods.

Do not expect conspicuous granulomas in profoundly immunodeficient MAC disease.

Do not assume that NTM typically spreads between people.

Slide 63 · Integrating NTM pathobiology

Environmental organism or device biofilm

Host susceptibility + tissue site

Pulmonary, localized or disseminated pathology

Species identity modifies clinical interpretation and treatment selection.

Slide 64 · Five points for clinicopathologic practice

MAC, M. Abscessus complex and M. Kansasii are leading NTM pathogens.

Environmental acquisition predominates; Interpersonal spread is uncommon.

Damaged lungs and impaired cellular immunity produce different syndromes.

MAC can produce massive macrophage-associated AFB in advanced HIV.

Species-level identification is necessary because treatment differs.

Slide 65 · Selected references

Robbins, Cotran & Kumar: Pathologic Basis of Disease (11th edition).

Core textbook section: “Nontuberculous Mycobacterial Infections.”

Related sections used for context: “Mycobacterial Infections” and “Bronchiectasis.”

Additional pathophysiology context: cystic fibrosis pulmonary disease.

Complete chapter, page and slide-level source mapping is provided in the presenter notes.